1832 Asset Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-78
Closed -$2.59K – 988
2024
Q1
$2.59K Buy
+78
New +$2.67K ﹤0.01% 840
2022
Q2
– Sell
-56,105
Closed -$2.73M – 977
2022
Q1
$2.73M Buy
56,105
+47,500
+552% +$2.51M ﹤0.01% 499
2021
Q4
$439K Buy
+8,605
New +$473K ﹤0.01% 483
2016
Q4
– Sell
-151,500
Closed -$9M – 768
2016
Q3
$9M Buy
151,500
+150,221
+11,745% +$9.23M 0.03% 275
2016
Q2
$80K Buy
+1,279
New +$78.7K ﹤0.01% 496

Other funds holding XRAY

1832 Asset Management's XRAY Position: Q2 2024 in Review

1832 Asset Management sold out of Dentsply Sirona (XRAY) in Q2 2024, closing a stake of 78 shares — an estimated $2.59K sold.

1832 Asset Management first reported a position in XRAY in Q2 2016 and held it in 5 quarters. The position peaked at $9M in Q3 2016. 381 funds tracked by Wall St. Rank hold XRAY as of Q2 2024.

  • 1832 Asset Management reported no remaining Dentsply Sirona position as of Q2 2024 after selling out during the quarter.
  • 1832 Asset Management sold 78 Dentsply Sirona shares in Q2 2024, an estimated $2.59K.
  • 1832 Asset Management first reported a position in Dentsply Sirona in Q2 2016 and held it in 5 quarters.
  • 1832 Asset Management's Dentsply Sirona position peaked at $9M in Q3 2016.
  • 381 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2024.

Based on 1832 Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.